The critical role of inflammation and immune activity in neurological diseases. It covers emerging insights into microglial function, cytokine signaling, blood–brain barrier disruption, and neuroimmune interactions that drive conditions such as multiple sclerosis, Alzheimer’s disease, and neurodegenerative disorders. Participants will explore diagnostic biomarkers, therapeutic targets, and innovative interventions aimed at modulating neuroinflammation to improve neurological outcomes.